36- Depression Flashcards

1
Q

name the two types of depression

A

unipolar
bipolar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe characteristics & symptoms of unipolar depression

A

most common depressive disorder
environmental and genetic factors at play
associated with stressful life events

symptoms: range from mild to severe
- depressive mood swings
- hallucinations and delusions in severe cases, psychotic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe characteristics & traits of bipolar depression

A

strong genetic factors, can be triggered by stress in adult life
oscillations between depressive and manic episodes

two types - type I and II
- type I = major manic episodes with/ without depression
- type II = hypomania, a less severe form of mania, with major depressive episodes

symptoms:
- manic episodes = self-confidence, excessive enthusiasm, impulsivity, aggression and irritability
- oscillations between depressive and manic episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

criteria for diagnosis

A

according to DSM-V, person must exhibit 5 or more symptoms within a 2-week period

  • depressed mood
  • appetite and weigh changes
  • loss of interest or pleasure
  • psychomotor changes - slowing down of thoughts, reduced physical movement
  • fatigue
  • feeling worthless, inappropriate guilt
  • suicidal thoughts = recurrent thoughts of death, suicidal ideation, a suicide attempt
  • cognitive impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

division of symptomology into emotional and biological

A

emotional symptoms
- apathy, pessimism, negativity
- low self-esteem and feeling guilty
- loss of motivation
- indecisiveness

biological symptoms
- reduced activity
- loss of libido
- sleep disturbances
- loss of appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe co-morbidity associated with depression

A

medical conditions associated with depression such as - drug abuse, anxiety, Parkinson’s, thyroid dysfunction and neurological disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

define the two theories that may explain the biological basis of depression

A

monoamine theory = downregulation of noradrenaline, 5-HT and their post-synaptic receptors

neuroendocrine theory = an extension of the monoamine theory and dysregulation of the HPA axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe the monoamine theory

A

decrease in NA and 5-HT release - brain should respond through neuroplasticity and increase post-synaptic receptors, increasing sensitivity and responsiveness to NTs

in depression - downregulation of 5-HT, NA and their post-synaptic receptors

imbalances cause long-term changes in gene expression, growth factors, neuronal loss and monoamine regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

evidence for and against the monoamine theory

A

evidence for:
- reserpine decrease 5-HT and noradrenaline, induces depression
- some antidepressants work by increasing monoamine levels, relieving depressive symptoms

evidence against:
- individual responses towards antidepressants - some don’t experience relief of depressive symptoms despite monoamine increase
- plasma and CSF levels of NA and 5-HT are normal between depressed and healthy individuals
- delayed onset of therapeutic effects of antidepressants = suggests secondary adaptive changes in the brain (neuroplasticity) may be needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the neuroendocrine theory behind depression

A

extension of the monoamine theory with dysfunction of the HPA axis - two aspects of it are increased plasma cortisol and neuronal loss

increased plasma cortisol:
- 5-HT and noradrenaline released from neurons and act on the hypothalamus
- hypothalamus release CRH
- anterior pituitary releases ACTH
- ACTH acts on the adrenal cortex = cortisol released
- increased plasma cortisol and CSF CRH in depressed individuals

neuronal loss:
- neuronal loss = decreased neural activity especially in hippocampus and pre-frontal cortex due to decrease in 5-HT levels
- 5-HT along with BDNF mediates/promotes neurogenesis and synaptic plasticity
- excess glutamate levels also associated = can cause excitotoxicity and neuronal cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe glutamate’s role in depression

A

excess glutamate can alter neurotransmission and induce excitotoxicity - neuronal cell death and damage

NMDA receptor antagonists like ketamine can relieve depressive symptoms by decreasing glutamate activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

evidence supporting the neuroendocrine theory

A
  • decreased BDNF in depressed patients
  • observed neuronal loss and decreased neural activity in the hippocampus and prefrontal cortex = explains emotional dysregulation and indecisiveness in depression. antidepressants promote neurogenesis in these areas
  • ketamine-like drugs can modulate glutamate, have fast-acting anti-depressive effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe the psychological treatments available for treating depression

A

cognitive behavioural therapy - improving behaviours and mood by helping patients change negative cognitive processes

interpersonal therapy - assume depression is multi-factorial and interpersonal difficulties play a role in maintaining depressive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

name the three main types of antidepressants

A

tricyclic antidepressants (TCAs)
monoamine oxidase inhibitors
SSRIs/ selective serotonin reuptake inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mechanism of action of tricyclic antidepressants?

A

block serotonin and NA reuptake, increasing their conc the synaptic cleft

downregulates alpha and beta adrenoreceptors, histamine receptors, muscarinic Ach receptors, and 5-HT 1A-D and 2A receptor subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

side effects of TCAs?

A

antimuscarinic effects - dry mouth, blurred vision, urinary retention and constipation

CVS effects - orthostatic hypertension from acting on a1 adrenoreceptor, tachycardia form acting on b1 receptors

histamine receptor effects - sedation

17
Q

examples of TCAs?

A

amitriptyline
imipramine

18
Q

mechanism of monoamine oxidase inhibitors as antidepressants?

A

inhibit MAO-A and B activity in breaking down monoamines

dopamine is broken down by MOA-B
serotonin and NA by MAO-A

increasing their conc in the synaptic cleft

19
Q

side effects of MAOIs?

A

severe hypertension, headaches and risk of intracranial haemorrhage - ‘cheese effect’, MAOIs interacting with decongestants/ amphetamines

serotonin syndrome

chronic use leads to downregulation of 5-HT, NA and dopamine receptors

20
Q

explain the ‘cheese effect’ with MAOIs

A

tyramine-rich dietary foods - e.g. yoghurt, cheese, wine, meat - excessively NA, acts on adrenoreceptors and can cause severe hypertension

21
Q

explain serotonin syndrome with MAOIs

A

MAOIs and SSRIs used together = excessive increase in 5-TH which can be life-threatening

22
Q

why is moclobemide a better choice of MAOI?

A

reversible inhibition - allows for temporary accumulation of noradrenaline and lower risk of severe hypertension and the ‘cheese effect’

23
Q

mechanism of action of SSRIs?

A

selectively block serotonin reuptake, inhibit SERT transporter

downregulate 5-HT1A-D autoreceptors, increase 5-HT release

therapeutic effects take time to develop for increase 5-HT levels to downregulate autoreceptors and normalise synaptic 5-HT activity

24
Q

side effect of SSRIs?

A

nausea, headaches and GI distress from stimulating 5-HT3 receptors - increased violence and sexual behaviour

insomnia and sexual dysfunction from stimulating 5-HT2 receptors

short half life, higher risk of withdrawal effects when discontinuing

risk of serotonin syndrome, seizures, cardiovascular collapse and hyperthermia if used with MAOIs or TCAs

25
Q

describe future treatments for antidepressants

A

drugs affecting monoamine transmission: modulating dopamine and serotonin release
- beta-3 agonists = modulate NT release
- DA agonists/ antagonists
- 5-HT1A/ 2A antagonists

drugs affecting ion channels:
- nicotinic Ach receptor modulators - agonists, antagonists, partial agonists
- NMDA receptor antagonists - e.g. ketamine = proven to have rapid antidepressant effects and less side effects, though there are addictive and hallucinogenic properties
- AMPA agonists = enhance synaptic plasticity with antidepressant effects
- modulate K+ IC activity

cortisol receptor antagonists = regulate stress response, high cortisol linked to neuroendocrine theory and HPA dysfunction

M1/M2 muscarinic Ach agonists = modulate Ach activity influences mood

NK1/2 neurokinin antagonists = modulate neuropeptide signalling involved in stress and mood regulation

26
Q

problems with current antidepressants

A

side effects:
SSRIs = insomnia, GI distress, nausea, sexual dysfunction, headaches
MAOIs = severe hypertension, serotonin syndrome, headaches, risk of intracranial haemorrhage
TCAs = orthostatic hypotension, antimuscarinic effects, sedation, tachycardia

  • delayed onset of therapeutic effects, challenging to those that need immediate relief
  • toxicity, risk of overdose, insomnia side effect can risk relapse
  • limited efficacy with severe depression
  • individual variation in treatment response = non-responsive in some, can be because of genetic variations, personalised medicines can enhance treatment outcomes
  • risk of withdrawal and relapse after discontinuation
27
Q

how is lithium used as a bipolar disorder treatment - mechanism of action and therapeutic use?

A

mechanism of action:
- enters neurons and remains there leading to depolarisation
- inhibits enzymes involved in signal transduction, prevents IP3 and cAMP activity as second messengers

use:
- prevents depressive episodes in bipolar disorder, treats manic episodes BUT with delayed onset of therapeutic effects (3-4 weeks)

28
Q

side effects of lithium as a bipolar disorder treatment?

A
  • drowsiness, confusion, vomiting
  • seizures, coma
  • weight gain
  • increased aldosterone = sodium retention
  • narrow therapeutic window between a therapeutic and toxic dose - constant monitoring for toxicity and effectiveness of treatment
29
Q

how is electroconvulsive therapy used as a treatment for bipolar disorder

A

doesn’t alter monoamine (5-HT or dopamine) levels or activity

involves sending an electric current through the brain, causes a brief surge of electrical activity within your brain

30
Q

alternate treatments for bipolar disorder?

A

ion channel blockers - e.g. valproate, carbamazepine

antipsychotics for mania = D2 or 5-HT2A receptor antagonists